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Abstract 
Aims/hypothesis 
Successful outcomes have been obtained by exploiting adipose-derived stem cells (ASCs) in 
regenerative medicine. NADPH oxidase (NOX)-generated reactive oxygen species (ROS) are 
known to control stem cell self-renewal. Several high glucose (HG)-mediated effects depend on 
NOX-generated ROS. In this study, we investigated whether, and how mechanistically, HG 
concentrations control ASC fate in patients with diabetes. 
Methods 
ASCs from the visceral adipose tissue of non-diabetic (N-ASCs) and diabetic participants (D-
ASCs), identified by surface markers, were counted and evaluated for ROS generation and stem cell 
properties. Their ability to release soluble factors was assessed by BioPlex analysis. To reproduce 
an invitro diabetic glucose milieu, N-ASCs were cultured in HG (25 mmol/l) or normal glucose 
(NG) concentration (5 mmol/l), as control. ASC pluripotency was assessed by in vitro study. The 
p47phox NOX subunit, AKT and octamer-binding transcription factor 4 (OCT4; also known as 
POU5F1) were knocked down by small-interfering RNA technology. Stem-cell features were 
evaluated by sphere cluster formation. 
Results 
The ASC number was higher in diabetic patients than in non-diabetic controls. Production of OCT4 
and NANOG, stem-cell-specific transcription factors, was upregulated in D-ASCs compared with 
N-ASCs. Moreover, we found that ROS production and AKT activation drove D-ASC, but not N-
ASC, secretion. When N-ASCs were cultured in vitro in the presence of HG, they also expressed 
OCT4/NANOG and formed spheres. By knock-down of the p47phox NOX subunit, AKT and OCT4 
we demonstrated that NOX-generated ROS and their downstream signals are crucial for HG-
mediated ASC de-differentiation and proinflammatory cytokine production. 
Conclusions/interpretation 
We herein provide a rationale for exploiting D-ASCs in regenerative medicine and/or exploiting 
HG preconditioning to increase ASCs ex vivo. 
Electronic supplementary material 
The online version of this article (doi:10.1007/s00125-012-2734-7) contains peer-reviewed but 
unedited supplementary material, which is available to authorised users. 
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Introduction 
Human adult mesenchymal stem cells (MSCs), owing to their useful properties, have become of 
increasing interest to clinicians [1–4]. Indeed, their ability to differentiate into several mesenchymal 
lineages has spurred clinicians to exploit these cells in tissue engineering and in regenerative 
medicine to repair damaged organs [1–4]. Different tissues have been discovered as sources of adult 
stem cells and recently adipose tissue has been considered a novel promising, abundant and 
accessible resource of adipose-derived stem cells (ASCs) [5–7]. Successful outcomes have been 
reported from a number of clinical trials exploiting ASCs, mainly in regeneration or repair of failing 
organs [8], although a number of relevant issues remain to be clarified. In particular, whether the 
therapeutic effect of ASCs depends merely on their engraftment and differentiation is still debated 
[9]. Moreover, very few data are as yet available on the molecular mechanisms that regulate their 
self-renewal and differentiation, both in physiological and pathological settings [10]. 
The stem cell microenvironment, the ‘stem cell niche’, in adipose tissue is crucial for preserving 
ASC self-renewal, denoting ‘stemness’ potential and controlling differentiation [11]. To date, data 
have been provided on the negative effects of obesity on the adipogenic niche [10]. However, how 
mechanistically abnormal metabolic conditions act on niches to control ASC fate is still poorly 
understood. Likewise, whether and how abnormal metabolic conditions might alter the ability of 
ASCs to release soluble mediators, a mechanism required for their therapeutic potential [12], is still 
unknown. 
Stem cell pluripotency and differentiation are strictly controlled by a coordinated network of 
transcription factors [13]. Among them, octamer-binding transcription factor 4 (OCT4) and 
NANOG, the levels of which are strictly controlled by OCT4 and SRY-box 2 (SOX2) [14], have 
been long recognised as crucial transcriptional regulators of stem cell self-renewal during 
embryogenesis [15]. More recently, it has been shown that both OCT4 and NANOG are also 
produced by adult undifferentiated MSCs and can be recovered from bone marrow, human cord 
blood and umbilical cord matrix [15-19]. 
The ability to reciprocally de-differentiate, re-differentiate or trans-differentiate in response to a 
specific stimulus is defined as cell plasticity [20-22]. OCT4 overexpression has been shown to 
induce de-differentiation of ASCs into a more immature status by activating the 
AKT/phosphoinositide 3-kinase (PI3K) and extracellular signal-related kinase (ERK1/2) signalling 
pathways [23]. As in developmental processes, in adult tissues several factors are engaged to 
modulate and maintain the balance between self-renewal and differentiation [21,22]. Indeed, it has 
been reported that ASCs possess their own multipotency to reprogramme into more primitive stem 
cells [23]. However, how this process takes place mechanistically is still controversial. 
NADPH oxidase (NOX)-mediated reactive oxygen species (ROS) production [24] has been 
reported to be involved in the control of stem and progenitor cell fate [25], as well as in neural cell 
reprogramming [26]. Likewise, ROS generation in response to hypoxia seems to control ASC 
proliferation [27]. 
In the diabetic setting, hyperglycaemia, via NOX enzymatic activity, upholds the production of 
ROS, which in turn acts as a second messenger [28]. Collectively, this might suggest that high 
glucose (HG) levels, a common feature in diabetes, might also regulate the fate or functional 
behaviour of stem cells in visceral adipose tissue by activating downstream signals. The present 
study aimed to investigate whether HG might dictate the balance between self-renewal and 
differentiation of ASCs in the ‘niche’ and, if so, how HG acts. In particular, this study aimed to 
investigate the potential clinical application of ASCs in diabetic patients. 
Methods 
Patients and controls 
A total of 25 type 2 diabetic patients and 15 non-diabetic participants who underwent abdominal 
surgery (gallbladder removal, in situ colorectal cancer) in our clinic were included. Non-diabetic 
participants were used as controls. Biometric data from the participants are reported in the 
electronic supplementary material (ESM) Table 1. Ethics approval was obtained from the 
Institutional Review Board of S. Giovanni Battista Hospital, Turin, Italy. Informed consent was 
obtained according to the Helsinki Declaration. We also declare that for the present study, we had 
no direct contact with the participants. 
Isolation of human visceral-derived ASCs 
Human visceral adipose tissue samples were recovered from 20 type 2 diabetic patients (D-ASCs) 
and 10 non-diabetic controls (N-ASCs) and processed as detailed in the ESM Methods. To select 
the ASC subpopulation from the stromal vascular fraction, cells obtained from an additional five 
patients and five controls were subjected to CD31 and CD45 negative selection by magnetic cell 
sorting and characterised as detailed in the ESM Methods [29]. Alternatively, visceral N-ASCs 
were maintained in normal glucose (NG) DMEM (5 mmol/l d-glucose), HG DMEM (25 mmol/l d-
glucose) or high mannitol (HM) DMEM (19 mmol/l d-mannitol, as osmotic control) and processed. 
Cell viability was evaluated at the end of each experiment using Trypan Blue or MTT assay. 
ASC proliferation 
Cell proliferation was assayed at different time intervals by direct cell count or FACS analysis 
(FACSCalibur flow cytometer; BD Biosciences, San Jose, CA, USA) using the proliferating cell 
nuclear antigen (PCNA) antibody [30]. Alternatively, cell proliferation was performed at day16 
after 48 h apocynin treatment or p47phox silencing on HG-cultured N-ASCs [31]. 
Detection of apoptosis 
Apoptosis was evaluated as indicated by a Cell Death Detection ELISAPLUS kit (Roche, Mannheim, 
Germany), following the manufacturer’s instructions. 
Senescence assay 
Senescence was evaluated by measuring the acidic β-galactosidase activity of N-ASCs that were 
differently cultured, as previously described [32]. 
ASC characterisation 
Freshly isolated ASCs, before or after magnetic cell-sorting selection, were characterised by FACS 
analysis. 
Endothelial and adipogenic ASC differentiation 
Cell multipotency was assessed under appropriate culture conditions. 
RNA isolation and quantitative real-time PCR 
Total RNA was isolated as previously described [31] from freshly or cultured ASCs, differently 
treated, and from ‘spheroids’, as indicated. IL6, IL8, TNFα (also known as TNFA) and IL1β (also 
known as IL1B) mRNA quantification was performed by quantitative real-time PCR (qRT-PCR). 
Western blot 
Cells were lysed and 50 µg of protein was subjected to SDS-PAGE, and processed as described 
[33]. 
Endogenous p47phox, OCT4 and AKT silencing by small interfering RNA 
To transiently knock down p47phox, OCT4 or AKT duplex small-interfering RNA (siRNA) (Qiagen, 
Valencia, CA, USA) was used. 
Sphere cluster (spheroid) formation 
ASC de-differentiation status was evaluated by a sphere cluster formation and clonogenic assay. 
Sphere cluster formation was evaluated by three different operators counting 10 fields at ×20 
magnification and reported as number±SD of spheres per field. 
ROS detection 
Cellular ROS level detection on ASCs, cultured and treated as indicated, was performed by using 
DCF-DA (5-[and-6]-carboxy-2′,7′-dichlorofluorescein diacetate, 0.5 µmol/l final concentration) 
(Molecular Probes, Invitrogen, Carlsbad, CA, USA) assay. 
Mitochondria isolation and measurement of complex I–III activity 
Cells incubated in the absence or presence of rotenone (50 µmol/l for 18 h) were lysed and treated, 
as detailed in the ESM Methods, to recover cytoplasmic mitochondria and measure complex I–III 
activity. 
Cytokine detection 
Conditioned media from 14 days of NG or HG cultures were collected and processed to detect the 
levels of cytokines by a BioPlex Array Reader (Bio-Rad Laboratories, Hercules, CA, USA). 
Statistical analysis 
Data are representative of at least three independent experiments, performed in triplicate, unless 
otherwise indicated. Densitometric analysis was used to calculate the differences in the fold 
induction of protein levels and normalised, with a statistically significant difference between 
experimental and control values indicated by p< 0.05. Western blot panels and relative 
densitometric histograms reported as ‘relative units’ in the figures are representative of the results 
obtained by experiments performed in triplicate (n=3, n=4 or n=5). The significance of 
differences between experimental and control values (indicated by p <0.05) was calculated 
using ANOVA with Newman–Keuls and Tukey multicomparison tests. ANOVA multicomparison 
testing was also used. 
All of the methods described above are fully detailed in the ESM Methods. Reagents and antibodies 
are also reported in the ESM Methods. 
 Results 
Characterisation of ASCs derived from diabetic patients 
To investigate whether environmental cues such as hyperglycaemia can control the fate of visceral-
derived ASCs, D-ASCs were compared with N-ASCs. ASC availability was first evaluated. An 
average (mean±SEM) of 9.16×104±9.2×104 and 5.95×104±7.5×104 
ASCs per gram of visceral adipose tissue were isolated from patients and controls, respectively 
(Fig. 1a). However, as such a population also contains the stromal vascular fraction, to attain 
purified ASCs, cells recovered from additional patients and controls (five of each) were subjected to 
CD31 and CD45 negative selection by magnetic cell sorting [29] and counted. An average 
(mean±SEM) of 4.58×104±3.2×104 and 1.9×104±2.8×104 ASCs per 
gram of visceral adipose tissue were isolated from patients and controls, respectively (ESM 
Fig. 1a). Cell viability was evaluated by Trypan Blue staining and by MTT assay (data not shown). 
 
Fig. 1  
Characterisation of ASCs derived from diabetic patients and non-diabetic controls. (a) The number 
of visceral ASCs (mean±SEM) per gram of fat tissue at isolation. Data refer to type 2 diabetic 
patients (n=20 samples) or non-diabetic controls (n=10). *p<0.05, D-ASCs vs N-ASCs. 
(b) Representative FACS analysis of visceral-derived D-ASCs and N-ASCs soon after isolation. 
Isotype controls were included (black peaks). The percentage of expression±SD of CD44, 
CD29, CD90 and CD105 markers was obtained by analysing 20 D-ASC and 10N-ASC samples (for 
N-ASCs: CD44, 96±2%; CD29, 96±2%; CD90, 18±1%; CD105, 48±3%; for D-
ASCs: CD44, 95±3%; CD29, 93±1%; CD90, 62±2%; CD105, 62±4%). (c) Cell 
extracts from N-ASCs and D-ASCs were analysed by western blot for OCT4 (white bars) and 
NANOG (black bars) content by densitometry. Protein levels were normalised to tubulin content. 
The results are representative of three different experiments, each performed in triplicate (n=3). 
***p<0.001 vs equivalent group in N-ASCs 
Freshly isolated or purified ASCs were subsequently characterised for their expression profile. N-
ASCs and D-ASCs, before or after magnetic cell sorting, expressed similar levels of mesenchymal 
cell markers, such as CD29 and CD44. By contrast, levels of the stemness markers CD105 and 
CD90 were higher in ASCs from diabetic patients compared with those from non-diabetic controls 
(Fig. 1b and ESM Fig. 1b). ASCs maintain their multipotency, as demonstrated by their ability to 
differentiate into mature endothelial cells and adipocytes [5,34, as shown by the levels of specific 
differentiating markers (ESM Fig. 2). The finding that freshly recovered ASCs subjected to 
magnetic cell sorting did not produce KDR (kinase insert domain receptor, also known as vascular 
endothelial growth factor receptor 2 [VEGFR2]) (ESM Fig. 2b) further supports the conclusion that 
ASC purification was successfully performed. The observation that CD90 levels were higher in D-
ASCs than in N-ASCs led us to investigate the content of OCT4 and NANOG, two crucial stemness 
regulators [13-15]. We found that OCT4 and NANOG production was upregulated in D-ASCs in 
comparison with N-ASCs (Fig. 1c). The result was further confirmed on the CD31−/CD45− ASC 
subpopulation (ESM Fig. 1c), suggesting that the number of de-differentiated ASCs is increased in 
diabetic patients. 
HG induces NOX-mediated ROS production 
To investigate the involvement of ROS production in mediating ASC expansion in the diabetic 
condition, DCF-DA fluorescence assay was performed. As shown in Fig. 2a, ROS levels were 
higher in freshly recovered D-ASCs than in N-ASCs. To further confirm these results, DCF-DA-
fluorescence was also performed on the CD31−/CD45−ASC population. Again, ROS generation was 
higher in D-ASCs than in N-ASCs (ESM Fig. 1d). As hyperglycaemia is a common feature of 
diabetes, we hypothesised that ASC de-differentiation status could be reproduced in vitro by 
culturing N-ASCs in HG conditions. A total of 14 days of culture are required to select a 
CD31−/CD45− ASC population (ESM Fig. 3a) [6]. Thus, the impact of HG in mediating ROS 
generation was evaluated on freshly recovered ASCs cultured in HG-containing media for 14 days. 
The results reported in Fig. 2b, obtained by N-ASCs cultured with HG or NG, demonstrated that 
ROS production increased in response to HG, but not to NG. Hydrogen peroxide (H2O2)-treated 
cells were used as controls. To investigate the involvement of NOX in ROS generation, HG or NG 
cultures were subjected to apocynin treatment. Apocynin treatment was able to prevent HG-
generated ROS (Fig. 2c). As apocynin is known to act as a radical scavenger [35] and the assembly 
of p47phox and p67phox subunits is required for NOX enzymatic activity [36], N-ASCs endogenously 
depleted of p47phox (ESM Fig. 4a) were evaluated for ROS generation. As shown in Fig. 2c, knock-
down of p47phox prevented ROS production in HG-cultured N-ASCs. To exclude the possibility that 
mitochondria could contribute to ROS production, the mitochondrial complex I–III inhibitor 
rotenone [37] was added and ROS generation was evaluated. As shown in ESM Fig. 3b, HG-
dependent ROS production was not affected by rotenone treatment. These data were confirmed by 
measuring complex I–III activity (ESM Fig. 3c). Cell viability was evaluated by MTT assay (data 
not shown). 
 Fig. 2  
NOX-mediated ROS production controls ASC proliferation. (a) DCF-DA assay was performed 
soon after isolation on ASCs freshly recovered from the visceral adipose tissue of type 2 diabetic 
patients (D-ASCs; black line) or non-diabetic controls (N-ASCs; grey line), to evaluate intracellular 
ROS levels. The intracellular DCF fluorescence levels, generated by the presence of ROS, varied 
linearly with increasing concentrations of oxidants and for this reason were used as a marker to 
quantify intracellular ROS production. The result is representative of three different experiments, 
each performed in triplicate (n=3). (b) DCF-DA assay was performed on N-ASCs cultured for 
14 days in the presence of NG (dark-grey line) or HG (black line), to evaluate ROS generation. 
H2O2-treated cells (light-grey line) were used as a positive control for ROS generation. HG-cultured 
N-ASCs were also treated with apocynin (light-grey line) or depleted of p47phox by siRNA (grey 
line) and analysed for ROS generation. HG, black line. (c) Proliferation of visceral N-ASCs, 
cultured with NG (white squares), HG (black squares) or HM (black circles) (19 mmol/l, as osmotic 
control), was evaluated at different time intervals (as indicated) by a direct cell count. 
***p<0.001, N-ASCs cultured in NG or HM vs HG. (d) HG-cultured N-ASC proliferation was 
evaluated after apocynin treatment (48 h) or in cells depleted of p47phox at day 16 by direct cell 
count (black squares, HG; white squares, HG+apocynin; black circles, HG+p47phox siRNA). 
**p<0.01, HG+apocynin and HG+p47phox siRNA vs HG. Data reported in (c) and (d) 
are expressed as number±SD cells per field (×10 magnification). (e) An aliquot of N-ASCs 
cultured in NG or treated as indicated in panel (d) was analysed by western blot for cyclin D1 
(white bars), p21waf (black bars) and β-actin content; the graph shows densitometric data. The 
results are representative of three different experiments performed in triplicate (n=3). 
***p<0.001 vs equivalent protein in NG 
NOX-generated ROS are crucial for HG-mediated ASC proliferation 
To evaluate whether increased ROS levels translate into increased cell proliferation, NG- or HG-
cultured N-ASCs were analysed for their proliferative capability. Data reported in Fig. 2d, obtained 
by directly counting cells or analysing the abundance of a DNA-polymerase-δ auxiliary protein 
such as PCNA (ESM Fig. 5a), revealed the rate of cell proliferation was higher in HG-cultured N-
ASCs than in those that were cultured with NG. HM (19 mmol/l), used as osmotic control, had no 
effect (Fig. 2d and ESM Fig. 5a). MTT assay as well as the cell death detection ELISA assay, used 
as an index of DNA fragmentation (ESM Fig. 6), revealed that non-toxic ROS levels were 
generated in response to HG treatment. To investigate the role of ROS in HG-mediated N-ASC 
proliferation, HG-cultured N-ASCs were treated with apocynin for 48 h and evaluated for their 
ability to undergo cell proliferation. As reported in Fig. 2e and ESM Fig. 5b, the addition of 
apocynin led to a reduction of N-ASC proliferation. The inhibitory effect exerted by apocynin was 
further confirmed by analysing the content of cyclin D1 (a member of the cyclin protein family that 
drives the G1/S phase transition) and p21waf (a cyclin-dependent kinase inhibitor acting as a 
negative regulator of cell cycle progression at G1) (Fig. 2f). Similar results were obtained in N-
ASCs silenced for p47phox (Fig. 2e, f and ESM Fig. 5b). The finding that, when depleted of their 
signalling machinery, ASCs underwent cell senescence could provide an explanation for the 
reduced numbers of cells detected in these experimental conditions (ESM Fig. 5e). Conversely, both 
apocynin treatment and p47phox depletion did not affect N-ASC proliferation when cultured in the 
presence of NG (ESM Fig. 5c and 5d). 
HG drives OCT4 and NANOG expression by NOX-mediated ROS generation 
FACS analysis was performed to characterise HG- and NG-cultured N-ASCs. The data reported in 
Fig. 3a demonstrate that while N-ASCs cultured with HG for 14 days still contained CD90, those 
cultured with NG retained only mesenchymal cell markers (CD105+, CD29+ and CD44+). Similarly 
to D-ASCs, HG-cultured N-ASCs produced OCT4 and NANOG (Fig. 3b). Undifferentiated adult 
stem cells, unlike committed cells, grow in suspension and form sphere clusters, in an anchorage-
independent fashion [38]. Consistent with OCT4/NANOG content, only HG-cultured N-ASCs were 
able to form ‘spheroids’ (Fig. 3c). To investigate the role of ROS in this process, HG-cultured N-
ASCs were subjected to apocynin or depleted of p47phox and evaluated. Data reported in Fig. 4a 
demonstrate that NOX-mediated ROS generation is essential for spheroid formation. Moreover, the 
finding that both approaches were able to decrease OCT4/NANOG content (Fig. 4b) further 
sustains the conclusion that ROS generation is crucial to promote ASC de-differentiation. 
 Fig. 3  
HG induces OCT4 and NANOG production, as well as sphere cluster formation. (a) Representative 
FACS analysis of N-ASCs cultured for 14 days in NG or HG medium. Isotype controls were 
included (black peaks). The percentage of expression±SD of CD44, CD29, CD90 and CD105 
markers was obtained by analysing 10 different samples (NG-cultured N-ASCs: CD44, 96±2; 
CD29, 914; CD90, 19±2; CD105, 30±2; HG-cultured N-ASCs: CD44, 95±3; CD29, 
94±1; CD90, 79±3; CD105, 76±3). (b) Cell extracts from N-ASCs culture for 14 days 
with NG or HG were analysed by western blot for OCT4 (black bars) and NANOG (grey bars) 
content by densitometry. Protein levels were normalised to tubulin content. ***p<0.001. (c) 
Sphere cluster formation was evaluated 72 h after seeding N-ASCs cultured for 14 days in NG or 
HG in semi-solid medium, as described in the ESM Methods. Black bar, P1 HG; grey bar, P1 NG; 
white bar, P2 HG. **p <0.01, P1 NG vs P1 HG. The clonogenic potential of HG-cultured N-
ASCs was investigated by plating single cell suspension derived from P1 spheres for an additional 
48 h (P2 HG). †† p <0.01, P1 NG vs P2 HG. Sphere cluster formation was evaluated by three 
different operators (each experiment was performed in triplicate), counting 10 fields at ×20 
magnification and reporting as number±SD of spheres per field in the histogram. Scale bars indicate 
50 µm in P1 NG and P1 HG (×20 magnification) and 20 µm in P2 HG (×40 magnification). The 
results are representative of four individual experiments performed in triplicate (n=4) P1 
corresponds to sphere cluster formation; P2 corresponds to sphere cluster formation of P1-derived 
cells 
 Fig. 4  
NOX-mediated ROS generation in response to HG is crucial for both sphere cluster formation and 
OCT4/NANOG production. (a) N-ASCs, subjected to the indicated treatments, were plated in semi-
solid medium, as described in the ESM Methods, to assess sphere cluster formation. The histogram 
reports the number±SD of spheres per field, counting10 fields at ×20 magnification. Black bar, 
HG; dark-grey bar, HG+apocynin; light-grey bar, HG+p47phox siRNA; white bar, 
HG+OCT4 siRNA. Scale bars indicate 50 µm. **p<0.01. The results are representative of 
four different experiments performed in triplicate (n=4). (b) HG-cultured N-ASCs in the 
presence or absence of apocynin or depleted of p47phox were lysed and subjected to SDS-PAGE. 
White bars, OCT4; black bars, NANOG. **p<0.01. The filters were immunoblotted with anti-
OCT4, anti-NANOG and anti-tubulin antibodies. (c) Cell extracts from HG-cultured N-ASCs, 
depleted or not of OCT4, were analysed by western blot for cyclin D1 (white bars) and p21waf 
(black bars) content. Protein levels were normalised to β-actin content. ***p<0.001, 
HG+OCT4 siRNA-treated cells vs HG for cyclin D1 and p21waf content. The results are 
representative of three different experiments performed in triplicate (n=3) 
OCT4 is crucial for HG-mediated ASC de-differentiation 
ASCs overexpressing OCT4 have been shown to undergo cell reprogramming [23]. Thus, the 
involvement of OCT4 in controlling HG-mediated ASC de-differentiation was further investigated. 
As reported in Fig. 4a, knock-down of OCT4 (ESM Fig. 4b) prevented HG-induced sphere cluster 
formation. Consistently, decreased expression of cyclin D1 and increased expression of p21waf was 
detected (Fig. 4c) in OCT4-silenced cells. 
AKT activation is crucial for OCT4 and NANOG expression and for spheroid formation in response 
to HG 
AKT is crucial for OCT4-mediated de-differentiation [23], thus, the role of AKT in HG-mediated 
ASC reprogramming was investigated. As shown in Fig. 5a, AKT production could be detected in 
HG-cultured N-ASCs, but not in NG-cultured cells. To gain further insight into the role of AKT in 
regulating this process, functional studies were performed in AKT-silenced N-ASCs (ESM Fig. 4c). 
Data in Fig. 5b, c show that, as in apocynin-treated and p47phox-silenced N-ASCs, OCT4/NANOG 
content was reduced and spheroid formation prevented in N-ASCs endogenously depleted of AKT. 
Again, the content of cyclin D1 and p21waf validated these data (Fig. 5d). To further confirm the 
role of ROS in controlling AKT activation, N-ASCs were cultured in the presence of apocynin or 
depleted of p47phox. As reported in Fig. 5a in both culture conditions we failed to detect AKT 
activation. The finding that ROS generation was still detectable in AKT-depleted cells (Fig. 5e) 
indicates that ROS generation occurs upstream to AKT. 
 
Fig. 5  
ROS-mediated AKT activation is involved in sphere cluster formation and OCT4/NANOG 
production in response to HG. (a) N-ASCs cultured in different experimental conditions, as 
indicated, were lysed and analysed by western blot for pAKT (black bars) and normalised to total 
AKT content. (b) Cell lysates from HG-cultured N-ASCs endogenously depleted of AKT were 
subjected to SDS-PAGE. The filters were immunoblotted with anti-OCT4 and anti-NANOG 
antibodies. Protein levels were normalised to tubulin content. White bars, OCT4; black bars, 
NANOG. (c) Sphere cluster formation assay was performed by seeding HG-cultured N-ASCs 
untreated or silenced for AKT in semi-solid medium. Histogram reports the number±SD of 
spheres per field, counting 10 fields at ×20 magnification. Scale bars indicate 50 µm. **p<0.01, 
HG+AKT siRNA (black bar) vs HG (white bar). (d) N-ASCs cultured and treated as indicated 
above were analysed by western blot for cyclin D1 (white bars), p21waf (black bars) and β-actin 
content. (e) DCF-DA assay was performed on HG-cultured N-ASCs, silenced or not for AKT, to 
evaluate cellular ROS levels. The results are representative of three different experiments, each 
performed in triplicate (n=3). ***p<0.001 
ROS production and AKT activation are required for IL-6 and IL-8 production by spheroids 
The role of ROS in mediating ASC paracrine action has been reported [39]. Therefore, the 
contribution of ROS in mediating HG-induced soluble factor secretion was investigated. BioPlex 
analysis (on supernatant fractions) and qRT-PCR (on spheroids) were performed. As reported in 
Fig. 6, the amount of IL-6 and IL-8 produced by N-ASCs cultured in the presence of HG (Fig. 6a) 
and spheroids (Fig. 6c,e) was higher than in NG-cultured cells. Next, N-ASC cytokine production 
was analysed in p47phox and AKT-silenced cells. Data shown in Fig. 6 clearly demonstrate that 
NOX-generated ROS and AKT activation are required for IL-6 and IL-8 production in response to 
HG only, indicating that different mechanisms account for IL-6 and IL-8 production in NG-cultured 
N-ASCs (ESM Fig. 7a). Moreover, the finding that preventing spheroid formation by silencing 
p47phox and AKT led to reduced cytokine production sustains the possibility that N-ASC paracrine 
function is enhanced by their de-differentiation status. Consistent with this possibility, we found 
that the release of IL-6 and IL-8 was significantly reduced when HG-containing media were 
removed and replaced with NG (Fig. 6g). Finally, we failed to detect TNFα and IL-1βin our 
samples (Fig. 6b,d,f). 
 Fig. 6  
ROS generation and AKT activation are required for IL-6 and IL-8 production. (a, b) BioPlex 
analysis was performed, according to the manufacturer’s instructions, to detect IL-6, IL-8 (a) and 
TNFα and IL-1β (b) levels in sixfold-concentrated supernatant fractions, recovered from the 
indicated cultures. White bars, NG; light-grey bars, HG; grey bars, HG+p47phox siRNA; dark-
grey bars, HG+AKT siRNA; black bars, positive control. IL-6 or IL-8: ***p<0.001, HG-
cultured N-ASCs vs NG-cultured N-ASCs, ††† p<0.001, HG+p47phox siRNA and 
HG+AKT siRNA vs HG. TNFα and IL-1β: ***p<0.001, experimental vs control value. (c–
f) IL6 (c), IL1β (d), IL8 (e) and TNFα (f) mRNA quantification was performed by qRT-PCR on N-
ASCs pretreated as indicated and cultured in semi-solid medium (see sphere cluster formation assay 
in the ESM Methods). Fold expression of the indicated cytokines, normalised to GAPDH, is 
representative of ten samples. ***p<0.001, HG-cultured N-ASCs vs NG-cultured N-ASCs; †† 
p<0.01, HG+p47phox siRNA and HG+AKT siRNA vs HG for IL6; **p<0.01, HG-
cultured N-ASCs vs NG-cultured N-ASCs; † p<0.05, HG+p47phox siRNA and HG+AKT 
siRNA vs HG for IL8; ***p<0.001, experimental vs control value for TNFα and ILIβ. (g) 
BioPlex analysis was also performed to detect IL-6 and IL-8 levels on sixfold concentrated 
supernatant fractions, recovered from 14 days’ NG (dark-grey bars) and HG (white grey bars) 
cultures. Alternatively, HG medium was replaced for 48 h with NG medium (light-grey bars) and 
then collected to detect IL-6 and IL-8 (***p<0.001, NG and HG replaced with NG vs HG-
cultured N-ASCs). Black bars, positive control. In (a–d), supernatant fractions or mRNA obtained 
from activated macrophages were used as positive controls (+). The results in a and d are 
representative of three different experiments, each performed in triplicate (n=3) 
ROS generation and AKT activation are required for D-ASC cytokine production 
An increased level of proinflammatory cytokines is a common feature in diabetes [40]. Thus, we 
investigated whether D-ASC de-differentiation status might contribute to this proinflammatory 
profile. Soon after isolation, both freshly recovered and CD31−/CD45− ASCs were evaluated for 
their ability to produce IL-6 and IL-8 by qRT-PCR. As reported in Fig. 7 and ESM Fig. 7b, IL-6 
and IL-8 production was higher in D-ASCs than in N-ASCs in both conditions. To gain further 
insight into the mechanisms regulating proinflammatory cytokine production and to avoid long-
term culture conditions, apocynin and the specific AKT inhibitor TCL110–24 were used instead of 
siRNA technology. Indeed, by applying these approaches, we demonstrated that ROS generation 
and AKT activation are essential for IL-6 and IL-8 production (Fig. 7 and ESM Fig. 7b). Again, we 
failed to detect either TNFα or IL-1β. 
 
Fig. 7  
IL6 and IL8 expression by CD31−/CD45− selected ASCs. IL6, IL8, TNFα and IL1β mRNA 
quantification was performed by qRT-PCR on CD31−/CD45− N-ASCs (grey bars) and D-ASCs 
(striped bars). CD31−/CD45− D-ASCs were also treated for 6 h with apocynin (dotted bars) or with 
the AKT inhibitor TCL110–24 (black bars). Fold expression of the indicated cytokines, normalised to 
GAPDH, is representative of five samples tested. ***p<0.001, D-ASCs vs N-ASCs; ††† 
p<0.001, D-ASCs+apocynin and D-ASCs+TCL110–24 vs D-ASCs for IL6; 
***p<0.01, N-ASCs, D-ASCs+apocynin and D-ASCs+TCL110–24 vs D-ASCs for IL8; 
***p<0.001, experimental vs control value for TNFα and IL1β. mRNA from activated 
macrophages was used as positive control (white bars, +). The results are representative of five 
different experiments, each performed in triplicate (n=5) 
Discussion 
White adipose tissue, owing to the easy access by minimally invasive methods, is currently 
considered an alternative and valuable source of ASCs for tissue regeneration [5,7,41]. However, no 
data have been provided on how mechanistically the balance between self-renewal and 
differentiation in the ‘niche’ is regulated in pathological conditions. Likewise, studies evaluating the 
potential impact of ASCs in clinical settings where tissue regeneration is required are still 
unavailable. 
The ‘stem cell niche’ is a specialised microenvironment containing stem cells [42]. As in 
developmental processes, in adult tissues, the balance between self-renewal and differentiation of 
stem cells is strictly controlled by environmental cues [13-18,21,22]. In this study, we have 
demonstrated that hyperglycaemic conditions induce and maintain ASC pluripotency. Pluripotency 
factors, including stemness genes, provide fundamental mechanisms underlying the properties of 
stem cells [22]. OCT4, SOX2 and NANOG are known regulators of genes encoding molecules 
involved in the control of stem cell behaviours, including proliferation and differentiation 
[18,21,22]. We provide evidence that in D-ASCs, OCT4 and NANOG expression is upregulated 
compared with N-ASCs. Consistently, we found that HG-induced OCT4 and NANOG expression is 
associated with an increased rate of cell proliferation and with their de-differentiation status. 
siRNA-mediated gene knock-down, used to extend our knowledge on D-ASC stemness behaviour, 
further supports the role of OCT4 in promoting ASC de-differentiation. This suggests that the 
increased number of ASCs recovered from diabetic patients may be the result of HG concentrations 
in the adipose ‘stem cell niche’. 
Although cellular accumulation of ROS has been considered a crucial driver of cell death in 
different pathological settings [43], evidence has been provided that the reduction–oxidation 
balance plays a far more complex role in stem cell biology [26, 27, 44]. Our data demonstrated that 
HG challenge induces ‘non-toxic’ levels of ROS in ASCs. ROS generation mainly relies on NOX 
enzymatic activity [28], which in turn depends on its regulatory subunits, p47phox and p67phox [28]. 
The finding that p47phox knock-down prevented both ROS generation and ASC proliferation 
indicates that NOX-mediated ROS generation in response to HG acts as second messenger to drive 
ASC proliferation. Moreover, the observation that interfering with the mitochondrial electron 
transport system did not affect ROS production suggests that ROS generation in our experimental 
conditions mainly depends on NOX activity. We could not directly demonstrate the involvement of 
NOX in mediating ROS production in freshly isolated ASCs (to obtain p47phox endogenous 
depletion would require long-term culture conditions). However, the percentage of HbA1c detected 
in our patients leads us to speculate that, as in vitro, in D-ASC NOX might be crucial in driving 
ROS generation, eventually leading to the increased de-differentiation status. 
To increase stem cell proliferation and self-renewal potential, physiological levels of ROS are 
required [25, 26, 45]. Consistently, data provided by our study (demonstrating that by silencing 
p47phox, ASCs failed to form spheroids and did not express OCT4) indicate that NOX-generated 
ROS are also crucial for HG-driven ASC de-differentiation. Moreover, the possibility that a 
decrease in ROS cellular levels has a negative impact on ASC self-renewal is supported by the 
finding that NG-cultured N-ASCs were unable to form spheroids. 
Beside phagocytes, other cell types use NOX-generated ROS as a second messenger [46]. The 
activation of the MAPK and PI3K/AKT signalling pathways has been reported to be the result of 
NOX-generated ROS [27]. Le Belle et al have demonstrated that in neural stem cell populations, 
self-renewal is associated with the ROS-mediated PI3K/AKT signalling pathway [26]. In addition, 
it has been shown that ASC reprogramming induced by OCT4 overexpression engages the 
PI3K/AKT and JAK/STAT3 pathways [23]. By applying siRNA technology to knock-down NOX 
and AKT, we have demonstrated that AKT activation is also essential for HG-mediated 
OCT4/NANOG production and for spheroid formation. Moreover, data provided by knock-down 
AKT demonstrate that AKT is downstream to ROS and upstream to OCT4. Again, further support 
for the biological relevance of the AKT signalling pathway in driving HG-mediated ASC de-
differentiation is provided by data obtained from NG-cultured N-ASCs. 
ASCs, besides possessing the ability to regenerate damaged tissue, also secrete soluble mediators 
[12, 39, 47]. A great deal of interest in adipose tissue has been generated by the finding that ASCs, 
by means of their paracrine function, influence the inflammatory response [39, 47]. We demonstrate 
that microenvironmental cues, by inducing ASC de-differentiation, influence ASC functional 
behaviour, resulting in increased proinflammatory cytokine production. This suggests that ASCs, 
exposed to hyperglycaemic conditions via NOX-generated ROS and AKT activation, might actively 
participate in dysfunctional proinflammatory cytokine production. Epidemiological studies have 
described a clear link between the C-reactive protein-mediated inflammatory response, its inducer 
IL-6 and an increased cardiovascular risk profile [48]. Interventions aimed at ameliorating the 
metabolic profile lead to a reduction in proinflammatory protein plasma levels, including that of IL-
6 [49]. Consistently, our results show that restoring glucose concentrations leads to decreased IL-6 
and IL-8 production. Therefore, as particular attention has been dedicated to the detrimental 
consequences of hyperglycaemia, our data suggest that targeting hyperglycaemia could also 
represent a rational approach to interfering with the ASC dysfunctional cytokine profile. 
Adipose tissue transplantation has been proposed as a potential tool to provide favourable metabolic 
effects in diabetes [3]. Data provided herein open new perspectives for the clinical application of 
visceral ASCs in diabetic patients. The potential clinical impact is supported by the following 
observations. First, the number of ASCs recovered from the visceral adipose tissue of diabetic 
patients is increased compared with that of non-diabetic controls. Second, ASCs obtained from 
these patients have high content of OCT4/NANOG, and thus possess a wider therapeutic potential. 
Third, visceral adipose tissue could be an ideal source of autologous ASCs obtainable with 
minimally invasive procedures. Finally, consistent with data provided by omentectomy in humans 
[50], the removal of visceral adipose tissue, besides providing favourable metabolic effects, might 
also offer an additional advantage such as the possibility of exploiting ASCs to repair failing 
organs. However, we cannot exclude that as in hematopoietic systems, where a high ROS level is 
associated with a high proliferation rate and premature exhaustion of the self-renewal potential [25], 
HG concentrations in the visceral adipose tissue of diabetic patients could lead to a rapid exhaustion 
of ASC stemness capability, eventually translating in an accelerated impairment of the regenerative 
potential. Further studies are required to resolve this issue. 
Data have indicated that multipotent stem cells can be recovered from the adipose tissue of adults 
[8]. However, how metabolic conditions can modulate the balance between self-renewal and 
differentiation in the ‘niche’ is still unclear. In this study, we provide evidence that environmental 
cues impact ASC biological properties and significantly affect their stemness and secretion profile. 
Moreover, these results provide the rationale to develop therapeutic strategies exploiting adipose 
tissue as an easily accessible source of MSCs to repair failing organs in diabetic patients. 
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